Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00902447 · ClinicalTrials.gov registry record

Human Blood Cell Disorders Tissue Bank

A clinical trial of Human Blood Cell Disorders and Lymphoid, Myeloid and Erythroid Proliferative Disease, sponsored by Northwell Health.

Recruiting
Registry status
10,000
Enrollment target
1
Study location

NCT00902447 is a study of Human Blood Cell Disorders and Lymphoid, Myeloid and Erythroid Proliferative Disease that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 10,000 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00902447, a study of Human Blood Cell Disorders and Lymphoid, Myeloid and Erythroid Proliferative Disease, is actively recruiting participants, sponsored by Northwell Health.

RECRUITING
Registry status
10,000 participants
Enrollment target
1
Study location

Study Summary

The Human Blood Cell Disorder Tissue Bank will provide a convenient, comprehensive source of tissue containing populations of human blood cells from patients with various types of lymphoid, myeloid, and erythroid proliferative diseases as well as other associated conditions. The tissue bank will continue to be an invaluable asset for understanding of the biology of multiple blood cell disorders involving several cell types as well as the physiology of normal cellular counterparts affected in these disorders. Internal and external investigators will be able to utilize this tissue to test hypotheses relating to the immunologic, virologic, genetic, and molecular properties of these abnormal cells as well as normal cells from normal unaffected family members or normal aged matched subjects to provide better comparisons.

Study Locations (1)

New York

  • The Feinstein Institute for Medical Research - Manhasset

Trial Details

FieldValue
Enrollment Target 10,000 participants
Start Date 2009-04
Est. Completion 2035-01

Sponsor

Northwell Health

370 total trials

What the Registry Record Tells You About NCT00902447

The ClinicalTrials.gov registry entry for NCT00902447 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Human Blood Cell Disorders appearing as the primary indexed condition, and to 0 interventions.

NCT00902447 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00902447 about?

NCT00902447 is a clinical study titled "Human Blood Cell Disorders Tissue Bank". The Human Blood Cell Disorder Tissue Bank will provide a convenient, comprehensive source of tissue containing populations of human blood cells from patients with various types of lymphoid, myeloid, and erythroid proliferative diseases as well as other associated conditions. The tissue bank will con...

What is the current status of trial NCT00902447?

This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2009-04. Estimated completion is 2035-01.

What conditions does trial NCT00902447 study?

This clinical trial studies the following conditions: Human Blood Cell Disorders, Lymphoid, Myeloid and Erythroid Proliferative Disease.

Who is sponsoring clinical trial NCT00902447?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00902447 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.